These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
897 related items for PubMed ID: 28082367
1. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. Bérard A, Zhao JP, Sheehy O. BMJ Open; 2017 Jan 12; 7(1):e013372. PubMed ID: 28082367 [Abstract] [Full Text] [Related]
2. Sertraline use during pregnancy and the risk of major malformations. Bérard A, Zhao JP, Sheehy O. Am J Obstet Gynecol; 2015 Jun 12; 212(6):795.e1-795.e12. PubMed ID: 25637841 [Abstract] [Full Text] [Related]
3. Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Chan JKN, Lee KCK, Wong CSM, Chang WC. Psychiatry Res; 2024 Sep 12; 339():116038. PubMed ID: 38889560 [Abstract] [Full Text] [Related]
4. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Bérard A, Sheehy O, Zhao JP, Vinet É, Bernatsky S, Abrahamowicz M. Br J Clin Pharmacol; 2017 May 12; 83(5):1126-1133. PubMed ID: 27874994 [Abstract] [Full Text] [Related]
5. Antidepressant use in pregnancy and the risk of cardiac defects. Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S. N Engl J Med; 2014 Jun 19; 370(25):2397-407. PubMed ID: 24941178 [Abstract] [Full Text] [Related]
6. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J. JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011 [Abstract] [Full Text] [Related]
7. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Ramos E, St-André M, Rey E, Oraichi D, Bérard A. Br J Psychiatry; 2008 May 01; 192(5):344-50. PubMed ID: 18450657 [Abstract] [Full Text] [Related]
8. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC. Encephale; 2010 Jun 01; 36 Suppl 2():D133-8. PubMed ID: 20513456 [Abstract] [Full Text] [Related]
9. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, Doyle P, Hubbard RB, Tata LJ. BJOG; 2014 Nov 01; 121(12):1471-81. PubMed ID: 24612301 [Abstract] [Full Text] [Related]
10. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. Dandjinou M, Sheehy O, Bérard A. BMJ Open; 2019 Oct 01; 9(9):e025908. PubMed ID: 31575566 [Abstract] [Full Text] [Related]
11. SSRI antidepressants and birth defects. Prescrire Int; 2006 Dec 01; 15(86):222-3. PubMed ID: 17167929 [Abstract] [Full Text] [Related]
12. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D. Birth Defects Res B Dev Reprod Toxicol; 2007 Feb 01; 80(1):18-27. PubMed ID: 17187388 [Abstract] [Full Text] [Related]
13. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. Kolding L, Ehrenstein V, Pedersen L, Sandager P, Petersen OB, Uldbjerg N, Pedersen LH. BJOG; 2021 Nov 01; 128(12):1949-1957. PubMed ID: 34036715 [Abstract] [Full Text] [Related]
14. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses. Uguz F. Expert Opin Drug Saf; 2020 Dec 01; 19(12):1595-1604. PubMed ID: 33001713 [Abstract] [Full Text] [Related]
15. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. Boukhris T, Sheehy O, Mottron L, Bérard A. JAMA Pediatr; 2016 Feb 01; 170(2):117-24. PubMed ID: 26660917 [Abstract] [Full Text] [Related]
16. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. Eke AC, Saccone G, Berghella V. BJOG; 2016 Nov 01; 123(12):1900-1907. PubMed ID: 27239775 [Abstract] [Full Text] [Related]
17. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH. BMC Med; 2018 Nov 12; 16(1):205. PubMed ID: 30415641 [Abstract] [Full Text] [Related]
18. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Källén BA, Otterblad Olausson P. Birth Defects Res A Clin Mol Teratol; 2007 Apr 12; 79(4):301-8. PubMed ID: 17216624 [Abstract] [Full Text] [Related]
19. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. Lupattelli A, Spigset O, Koren G, Nordeng H. J Clin Psychopharmacol; 2014 Feb 12; 34(1):143-8. PubMed ID: 24135843 [Abstract] [Full Text] [Related]
20. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study. Lupattelli A, Wood M, Lapane K, Spigset O, Nordeng H. Pharmacoepidemiol Drug Saf; 2017 Oct 12; 26(10):1266-1276. PubMed ID: 28815791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]